4,7-二氯-6-硝基-3-喹啉甲腈 | 263149-40-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4,7-二氯-6-硝基-3-喹啉甲腈
• 英文名称: 4,7-dichloro-6-nitro-3-quinolinecarbonitrile
• 英文别名: 4,7-Dichloro-6-nitroquinoline-3-carbonitrile
• CAS: 263149-40-2
• 化学式: C₁₀H₃Cl₂N₃O₂
• 分子量: 268.059
• InChiKey: YAIZQVOCMDSWBS-UHFFFAOYSA-N

物化性质

• 沸点：
  468.9±40.0 °C(Predicted)
• 密度：
  1.66±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  82.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4,7-二氯-6-硝基-3-喹啉甲腈 在 palladium on activated charcoal sodium azide 、 氢气 、 吡啶盐酸盐 作用下， 以 乙二醇乙醚 为溶剂， 生成 6,7-diamino-4-(5-methoxy-2-methylanilino)-3-quinolinecarbonitrile
  参考文献：
  名称：

  8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src Kinase Inhibitors

  摘要：

  A series of 8-anilinoimidazo[4,5-g]quinoline-7-carbonitriles was synthesized and evaluated as Src kinase inhibitors. Several aniline substituents were surveyed, as well as water-solubilizing groups at the C-2 and N-3 positions. Potent Src inhibitors were identified, with N-3 providing the best position for an additional water-solubilizing group. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00524-3
• 作为产物：
  描述：

  3-氯-4-硝基苯胺 在 sodium hydroxide 、 三聚氯氰 、 草酰氯 、 N,N'-羰基二咪唑 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 4,7-二氯-6-硝基-3-喹啉甲腈
  参考文献：
  名称：

  8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src Kinase Inhibitors

  摘要：

  A series of 8-anilinoimidazo[4,5-g]quinoline-7-carbonitriles was synthesized and evaluated as Src kinase inhibitors. Several aniline substituents were surveyed, as well as water-solubilizing groups at the C-2 and N-3 positions. Potent Src inhibitors were identified, with N-3 providing the best position for an additional water-solubilizing group. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00524-3

文献信息

• Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
  申请人：Wyeth Holdings Corporation

  公开号：EP1950201A1

  公开（公告）日：2008-07-30

  This invention provides compounds of formula 1 wherein R1, G1, G2, R4, Z, X and n are defined herein, or a pharmaceutically acceptable salt thereof, which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.

  这项发明提供了式1的化合物 其中R1、G1、G2、R4、Z、X和n在此处定义，或其药学上可接受的盐，这些化合物可用作抗肿瘤剂和多囊肾病的治疗药物。
• Substituted 3-cyanoquinolines
  申请人：American Cyanamid Company

  公开号：US06297258B1

  公开（公告）日：2001-10-02

  This invention provides compounds of formula I having the structure wherein G1, G2, R1, R4, Z, n, and X are defined in the specification or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.

  这项发明提供了具有结构的化合物I的公式，其中G1、G2、R1、R4、Z、n和X在规范中定义，或其药用盐，这些化合物可用作抗肿瘤剂，并用于多囊肾病的治疗。
• Tricyclic protein kinase inhibitors
  申请人：American Home Products Corporation

  公开号：US20010051620A1

  公开（公告）日：2001-12-13

  This invention provides compounds of formula 1, having the structure 1 which are useful as inhibitors of protein tyro sine kinase and are antiproliferative agents.

  这项发明提供了具有结构1的化合物，这些化合物可作为蛋白酪氨酸激酶的抑制剂，是抗增殖剂。
• [EN] TRICYCLIC PROTEIN KINASE INHIBITORS<br/>[FR] INHIBITEURS TRICYCLIQUES DE PROTEINE KINASE
  申请人：AMERICAN HOME PROD

  公开号：WO2001047892A1

  公开（公告）日：2001-07-05

  This invention provides compounds of formula (1) which are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents.

  本发明提供了一种式子为(1)的化合物，它们可用作蛋白酪氨酸激酶的抑制剂并具有抗增殖作用。
• USRE042376E1
  申请人：——

  公开号：——

  公开（公告）日：——